Acorda Therapeutics reported $-6199000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
ALKERMES ALKS:US USD -41044000 25.98M
Amgen AMGN:US USD 3.5B 62M
Aptinyx Inc APTX:US USD -14557000 2.45M
Arrowhead Research ARWR:US USD -81170000 10.86M
Biogen BIIB:US USD 992.8M 82.9M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Cara Therapeutics CARA:US USD -23783000 19.37M
Clovis Oncology CLVS:US USD -42347000 15.13M
Cytokinetics CYTK:US USD -107033000 97.57M
Gilead Sciences GILD:US USD 3.28B 731M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Insmed INSM:US USD -119864000 21.78M
Mannkind MNKD:US USD -9640000 13.91M
Merck MRK:GR EUR 1.81B 14M
Moderna Inc MRNA:US USD 1.28B 1.24B
Neurocrine Biosciences NBIX:US USD 91.8M 33.2M
Novartis NOVN:VX USD 4.69B 34M
Pfizer PFE:US USD 10.52B 2.78B
Teva Pharmaceutical TEVA:IT USD 1.06B 31M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M